US45719W2052 - IKT (XNAS)
Inhibikase Therapeutics, Inc. - Common Stock Aktie
1,16 USD
Aktuelle Kurse von Inhibikase Therapeutics, Inc. - Common Stock
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
IKT
|
USD
|
19.09.2024 21:59
|
1,16 USD
| 1,18 USD | -1,67 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -1,67 % | -8,63 % | -22,13 % | -39,88 % | 14,88 % | -98,05 % |
Firmenprofil zu Inhibikase Therapeutics, Inc. - Common Stock Aktie
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointestinal complications that arise as early symptoms of PD, such as swallowing, dysphagia, neurogenic constipation, and multiple system atrophy; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects and for the treatment of blood and stomach cancers. It is also involved in developing various research programs for other neurological diseases. The company has research and development collaborations with The Johns Hopkins University, Arizona State University, and Michigan State University, as well as Louisiana State University. Inhibikase Therapeutics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
Unternehmensdaten zur Inhibikase Therapeutics, Inc. - Common Stock Aktie
Name Inhibikase Therapeutics, Inc. - Common Stock
Firma Inhibikase Therapeutics, Inc.
Symbol IKT
Website https://www.inhibikase.com
Heimatbörse
NASDAQ
ISIN US45719W2052
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Milton H. Werner Ph.D.
Marktkapitalisierung 10 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 3350 Riverwood Parkway SE, 30339 Atlanta
IPO Datum 2020-12-23
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | IKT |
Weitere Aktien
Investoren die Inhibikase Therapeutics, Inc. - Common Stock halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024